Study reveals potential benefits of naloxone in opioid-associated cardiac arrest

Patients who overdose on opioids and have a pulse are often given naloxone (Narcan) by first responders, a common life-saving measure.

Grail faces uphill battle to get Medicare to cover its cancer screening test

WASHINGTON — Grail is aggressively lobbying to get Medicare to pay for its cancer-screening test Galleri — but experts tell STAT that the company has

June 27, 2023

EMA CHMP provides positive opinion for ViiV’s cabotegravir

Cabotegravir LA injectable and tablets are intended for usage as a pre-exposure prophylaxis to cut down HIV-1 infection risk. Credit: PENpics Studio / Shutterstock.com. The

July 25, 2023

PhoreMost reaches milestone in a target discovery alliance with Boehringer Ingelheim

PhoreMost Ltd., has triggered a milestone payment in its multi-project target discovery collaboration with Boehringer Ingelheim. This was achieved by identifying and validating novel targets

June 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.